PDEX
Pro-Dex, Inc.NASDAQHealthcare$51.67+1.33%ClosedMarket Cap: $168.5M
As of 2026-04-06
Valuation
P/E (TTM)
14.87
PEG
0.22
P/B
3.79
P/S
2.20
EV/EBITDA
9.34
DCF Value
$178.74
FCF Yield
3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
28.3%
Operating Margin
15.7%
Net Margin
15.7%
ROE
29.2%
ROA
18.2%
ROIC
15.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $18.7M | 30.8% | $3.3M | $2.2M | $0.66 | — |
| Q1 2026 | $18.5M | 29.0% | $3.1M | $4.7M | $1.40 | — |
| Q4 2025 | $17.5M | 19.9% | $1.3M | $1.2M | $0.36 | — |
| FY 2025 | $66.6M | 29.3% | $10.7M | $9.0M | $2.67 | — |
| Q3 2025 | $17.4M | 33.3% | $3.6M | $3.3M | $0.98 | — |
| Q2 2025 | $16.8M | 30.2% | $2.7M | $2.0M | $0.61 | — |
| Q1 2025 | $14.9M | 34.6% | $3.0M | $2.5M | $0.75 | — |
| Q4 2024 | $15.0M | 27.2% | $2.4M | $1.6M | $0.46 | — |
| FY 2024 | $53.8M | 27.0% | $7.2M | $2.1M | $0.60 | — |
| Q3 2024 | $14.3M | 28.0% | $2.2M | $655.0K | $0.19 | — |
| Q2 2024 | $12.6M | 22.3% | $777.0K | $500.0K | $0.14 | — |
| Q1 2024 | $11.9M | 30.6% | $1.8M | $-615.0K | $-0.17 | — |